Considering that proportions of CD4+ T subpopulations could be imbalanced between diabetic and non-diabetic CKD patients, we explored the so-called master regulator genes to characterize CD4+ T cells differentiation bias on this patient cohort. Here, CD4 is linked to chronic kidney disease.